Primary Sclerosing Cholangitis (PSC)
Welcome to the online home of the Chris M. Carlos and Catherine Nicole Jockisch Carlos Endowment for Primary Sclerosing Cholangitis (PSC). Thanks to support provided by this endowment, dedicated Mayo Clinic investigators and their teams are making strides to better understand and treat PSC patients, with the ultimate goal of developing a cure for this disease.
Follow the PSC page and stay up-to-date as we post news about advances in PSC research, clinical trials, and available resources.
IBD: A Comorbidity of PSC
The majority of patients with the PSC have Inflammatory Bowel Disease (IBD). The association of those two diseases is known for decades, yet the contribution of IBD in the development and outcomes of PSC remain sunclear. Morever, the presence of IBD among patients with PSC affects the medical and surgical management of these patients. Patients with PSC should understand the relationship and impact of IBD on PSC.
In this presentation, Dr. Laura Raffals, Associate Professor of Medicine, Mayo Clinic College of Medicine provides a comprehensive review of the epidemiology, diagnosis, outcomes and management of IBD among PSC patients.
View the powerpoint presentation from Dr. Raffals
Join others discussing PSC
Liked by Rosemary, Volunteer Mentor